BioSpace News Archive

ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces a Nature Neuroscience publication showing the potential for ONWARD’s ARCIM Therapy to restore movement and function in hands and arms after spinal cord injury.

PLT Health Solutions, Inc announced a new clinical study conducted with its AlvioLife® ingredient that provides further evidence in support of respiratory and immune health, as well as perceived immune function and well-being.

The U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities.

The latest market analysis report published by Reports and Data, titled ‘Global Vascular Graft Market – Forecast to 2028,’ thoroughly examines the Vascular Graft industry to provide essential data & information for the targeted readers.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop antibodies for applications in immuno-oncology.

HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from Ardelyx Japanese collaboration partner.

Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 4, 2022.

Melzi Surgical today announced that it will participate at the Society of Robotic Surgery 2022 Annual Meeting being held June 30 - July 3, 2022 in Lake Buena Vista, FL.

National Cancer Center Announces Recipients of 2022-23 Research Fellowship Awards.

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended March 31, 2022.